We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Not so well

27 November 2003 By Robert Cyran

The UK drugs firm is confronting unexpected generic competition to its blockbuster antidepressant. With more than 20% of its drug sales now up against generic competition, the company’s sales and profits are set to shrink in 2004.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)